好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Salvage Chemotherapy with CPT-11 for Recurrent Temozolomide-Refractory Anaplastic Oligodendroglioma
Neuro-oncology
(-)
001
Authors/Disclosures
Marc Chamberlain, MD (Cascadian Therapeutics) No disclosure on file
No disclosure on file
No disclosure on file
Sajeel Chowdhary, MD (Marcus Neuroscience Institute) Dr. Chowdhary has received personal compensation for serving as an employee of Merck. Dr. Chowdhary has received personal compensation for serving as an employee of Servier. Dr. Chowdhary has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Chowdhary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier.
Marko Petrovic, MD (Kaiser Permanente) Dr. Petrovic has nothing to disclose.
Deborah T. Blumenthal, MD (Intermountain Medical Center) Dr. Blumenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Affaires Medicales. Dr. Blumenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure Israel Ltd. Dr. Blumenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Oncology. The institution of Dr. Blumenthal has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Merck Sharp and Dohme.
Michael Glantz, MD, FAAN No disclosure on file